Vor bio reports fourth quarter and full year 2023 financial results and provides company update

Cambridge, mass., march 20, 2024 (globe newswire) -- vor bio (nasdaq: vor), a clinical-stage cell and genome engineering company, today reported financial results for the three-month period and full year ended december 31, 2023, and provided a business update.
VOR Ratings Summary
VOR Quant Ranking